(Q46136299)

English

Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study).

scientific article published on 9 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study). (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

Michael Hudgens

2

object named as

Michael G Hudgens

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

5

object named as

Kari Syrjänen

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

author name string

Joseph Monsonego

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

Laurent Zerat

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

Jean-Claude Zerat

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

Jennifer S Smith

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

language of work or name

0 references

publication date

9 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

125

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

175-180

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

Report on consensus conference on cervical cancer screening and management

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Reproducibility of classification and correction for verification bias as determinants of performance of Papanicolaou smear cytology in the screening setting: experience from the New Independent States of the former Soviet Union cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Liquid-based cytology for primary cervical cancer screening: a multi-centre study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Papillomaviruses in the causation of human cancers - a brief historical account

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Human papillomavirus testing for cervical cancer screening: results from a 6-year prospective study in rural China

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

How many cervical cancers are prevented by treatment of screen-detected disease in young women?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Value of conventional pap smear, liquid-based cytology, visual inspection and human papillomavirus testing as optional screening tools among latin american women <35 and > or =35 years of age: experience from the Latin American Screening Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Benefit of cervical screening at different ages: evidence from the UK audit of screening histories

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Analytical characterization of the APTIMA HPV Assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Human papillomavirus genotype specificity of hybrid capture 2

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Performance assessment of eight high-throughput PCR assays for viral load quantitation of oncogenic HPV types

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Real-time Taqman PCR targeting 14 human papilloma virus types

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Identifiers

10.1016/J.YGYNO.2012.01.002

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46136299&oldid=2043307833"